English
Insider transactions
EDGARJade Biosciences, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-18.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–14 of 14
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-25 Filed 2026-06-26 | Eisner Mark Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 47,675 | 0 | — | 47,675 | Direct (D) | No | F1
| Open filing 0001193125-26-286434 Read from the filing’s XML Dispute this row |
| 2026-06-09 Filed 2026-06-11 | Klein Lawrence Otto Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 34,843 | 0 | — | 34,843 | Direct (D) | No | F1
| Open filing 0001193125-26-267735 Read from the filing’s XML Dispute this row |
| 2026-06-09 Filed 2026-06-11 | Fairmount Funds Management LLC Director · 10% ownerFairmount Healthcare Fund II L.P. Director · 10% ownerFairmount Healthcare Co-Invest IV L.P. Director · 10% ownerKiselak Tomas Director · 10% ownerHarwin Peter Evan Director · 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 34,843 | 0 | — | 34,843 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-267706 Read from the filing’s XML Dispute this row |
| 2026-06-09 Filed 2026-06-11 | CAIN CHRISTOPHER W. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 34,843 | 0 | — | 34,843 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-267764 Read from the filing’s XML Dispute this row |
| 2026-06-09 Filed 2026-06-11 | DOBMEIER ERIC Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 34,843 | 0 | — | 34,843 | Direct (D) | No | F1
| Open filing 0001193125-26-267739 Read from the filing’s XML Dispute this row |
| 2026-06-09 Filed 2026-06-11 | Lavelle Erin Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 34,843 | 0 | — | 34,843 | Direct (D) | No | F1
| Open filing 0001193125-26-267708 Read from the filing’s XML Dispute this row |
| 2026-02-12 Filed 2026-02-13 | Frohlich Tom Director · Officer: Chief Executive Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 78,750 | 0 | — | 86,331 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-052054 Read from the filing’s XML Dispute this row |
| 2026-02-12 Filed 2026-02-13 | Frohlich Tom Director · Officer: Chief Executive Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 472,500 | 0 | — | 472,500 | Direct (D) | No | F3
| Open filing 0001193125-26-052054 Read from the filing’s XML Dispute this row |
| 2026-02-12 Filed 2026-02-13 | King Andrew James Officer: See Remarks | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 41,250 | 0 | — | 386,113 | Direct (D) | No | F1
| Open filing 0001193125-26-052053 Read from the filing’s XML Dispute this row |
| 2026-02-12 Filed 2026-02-13 | King Andrew James Officer: See Remarks | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 247,500 | 0 | — | 247,500 | Direct (D) | No | F2
| Open filing 0001193125-26-052053 Read from the filing’s XML Dispute this row |
| 2026-02-12 Filed 2026-02-13 | Dahms Bradford D. Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 37,813 | 0 | — | 37,813 | Direct (D) | No | F1
| Open filing 0001193125-26-052056 Read from the filing’s XML Dispute this row |
| 2026-02-12 Filed 2026-02-13 | Dahms Bradford D. Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 226,875 | 0 | — | 226,875 | Direct (D) | No | F2
| Open filing 0001193125-26-052056 Read from the filing’s XML Dispute this row |
| 2026-02-12 Filed 2026-02-13 | Balta Elizabeth Officer: See Remarks | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 28,125 | 0 | — | 28,125 | Direct (D) | No | F1
| Open filing 0001193125-26-052055 Read from the filing’s XML Dispute this row |
| 2026-02-12 Filed 2026-02-13 | Balta Elizabeth Officer: See Remarks | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 168,750 | 0 | — | 168,750 | Direct (D) | No | F2
| Open filing 0001193125-26-052055 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,793 filings read, the latest filed 2026-11-17. Prior quarter ending 2026-06-30: 9,164 filings read.
Showing 1–50 of 167
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| FMR LLC Partly reported under another manager | 9,810,088 SH | 137,831,737 dollars | Higher by 683,211 Prior quarter: 9,126,877 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| Janus Henderson Group Ltd. Partly reported under another manager | 6,991,676 SH | 98,113,949 dollars | Not in the prior quarter’s filings read | Open filing 0001085146-26-000952 Filed 2026-11-16 Dispute this row |
| Paradigm Biocapital Advisors LP | 6,053,268 SH | 85,048,415 dollars | Higher by 3,195,863 Prior quarter: 2,857,405 | Open filing 0001855655-26-000020 Filed 2026-11-16 Dispute this row |
| Fairmount Funds Management LLC | 4,553,494 SH | 63,976,591 dollars | Unchanged Prior quarter: 4,553,494 | Open filing 0001104659-26-128188 Filed 2026-11-16 Dispute this row |
| Bellevue Group AG Partly reported under another manager | 4,293,937 SH | 60,329,815 dollars | Higher by 1,235,941 Prior quarter: 3,057,996 | Open filing 0001104659-26-128575 Filed 2026-11-16 Dispute this row |
| FRANKLIN TEMPLETON INC Partly reported under another manager | 3,807,236 SH | 57,260,829 dollars | Higher by 1,015,156 Prior quarter: 2,792,080 | Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 3,366,725 SH | 47,302,485 dollars | Higher by 565,274 Prior quarter: 2,801,451 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| Venrock Adviser, LLC | 3,220,364 SH | 45,246,114 dollars | Unchanged Prior quarter: 3,220,364 | Open filing 0001615982-26-000019 Filed 2026-11-16 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 2,602,939 SH | 36,571,293 dollars | Higher by 267,654 Prior quarter: 2,335,285 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,345,833 SH | 32,958,954 dollars | Higher by 101,060 Prior quarter: 2,244,773 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| Avidity Partners Management LP | 2,000,000 SH | 28,100,000 dollars | Higher by 299,292 Prior quarter: 1,700,708 | Open filing 0001791827-26-000008 Filed 2026-11-16 Dispute this row |
| Polar Capital Holdings Plc Partly reported under another manager | 1,843,717 SH | 25,904,224 dollars | Lower by 3,265 Prior quarter: 1,846,982 | Open filing 0001172661-26-005169 Filed 2026-11-16 Dispute this row |
| RA CAPITAL MANAGEMENT, L.P. | 1,835,542 SH | 25,789,365 dollars | Lower by 1,835,541 Prior quarter: 3,671,083 | Open filing 0001104659-26-128411 Filed 2026-11-16 Dispute this row |
| Remedium Capital Partners, LLC Partly reported under another manager | 1,807,814 SH | 25,399,787 dollars | Higher by 230,064 Prior quarter: 1,577,750 | Open filing 0002104501-26-000021 Filed 2026-11-13 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 1,469,144 SH | 20,832,463 dollars | Lower by 5,935 Prior quarter: 1,475,079 | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager | 1,397,736 SH | 19,639 dollars | Higher by 1,371,190 Prior quarter: 26,546 | Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row |
| BAKER BROS. ADVISORS LP | 1,230,426 SH | 17,287,485 dollars | Unchanged Prior quarter: 1,230,426 | Open filing 0001104659-26-128308 Filed 2026-11-16 Dispute this row |
| Pictet Asset Management Holding SA | 1,205,972 SH | 16,943,907 dollars | Higher by 472,204 Prior quarter: 733,768 | Open filing 0001993888-26-000007 Filed 2026-11-03 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 1,201,913 SH | 16,892,198 dollars | Higher by 216,735 Prior quarter: 985,178 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| Soleus Capital Management, L.P. | 1,170,928 SH | 16,451,538 dollars | Lower by 379,762 Prior quarter: 1,550,690 | Open filing 0001802630-26-000008 Filed 2026-11-16 Dispute this row |
| Versant Venture Management, LLC | 991,783 SH | 13,934,551 dollars | Unchanged Prior quarter: 991,783 | Open filing 0001193125-26-460919 Filed 2026-11-13 Dispute this row |
| ACORN CAPITAL ADVISORS, LLC | 986,760 SH | 13,863,978 dollars | Unchanged Prior quarter: 986,760 | Open filing 0001636587-26-000102 Filed 2026-11-16 Dispute this row |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 950,000 SH | 13,347,500 dollars | Lower by 960,812 Prior quarter: 1,910,812 | Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 929,291 SH | 13,056,539 dollars | Lower by 116 Prior quarter: 929,407 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 896,834 SH | 12,600,518 dollars | Higher by 161,610 Prior quarter: 735,224 | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| Foresite Capital Management VI LLC | 886,667 SH | 12,457,671 dollars | Unchanged Prior quarter: 886,667 | Open filing 0001104659-26-128383 Filed 2026-11-16 Dispute this row |
| Affinity Asset Advisors, LLC | 760,350 SH | 10,682,918 dollars | Lower by 80,000 Prior quarter: 840,350 | Open filing 0001011438-26-000687 Filed 2026-11-13 Dispute this row |
| SAMSARA BIOCAPITAL, LLC | 736,237 SH | 10,344,130 dollars | Unchanged Prior quarter: 736,237 | Open filing 0001744967-26-000014 Filed 2026-11-16 Dispute this row |
| Blackstone Inc. Partly reported under another manager | 676,596 SH | 9,506,174 dollars | Higher by 241,276 Prior quarter: 435,320 | Open filing 0001193125-26-463513 Filed 2026-11-16 Dispute this row |
| LORD, ABBETT CO. LLC | 666,923 SH | 9,370 dollars | Higher by 440,317 Prior quarter: 226,606 | Open filing 0000930413-26-003314 Filed 2026-11-13 Dispute this row |
| Aberdeen Group plc Partly reported under another manager | 550,887 SH | 7,739,962 dollars | Lower by 70,221 Prior quarter: 621,108 | Open filing 0001716774-26-000032 Filed 2026-11-10 Dispute this row |
| BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager | 528,368 SH | 7,423,570 dollars | Higher by 328,939 Prior quarter: 199,429 | Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 521,682 SH | 7,329,632 dollars | Higher by 60,154 Prior quarter: 461,528 | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| STEMPOINT CAPITAL LP | 471,718 SH | 6,627,638 dollars | Not in the prior quarter’s filings read | Open filing 0001420506-26-002774 Filed 2026-11-16 Dispute this row |
| MARSHALL WACE, LLP Partly reported under another manager | 458,886 SH | 6,447,348 dollars | Lower by 126,875 Prior quarter: 585,761 | Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 444,165 SH | 6,240,518 dollars | Higher by 344,188 Prior quarter: 99,977 | Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row |
| Ikarian Capital, LLC | 427,349 SH | 6,004,253 dollars | Unchanged Prior quarter: 427,349 | Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row |
| MILLENNIUM MANAGEMENT LLC | 420,542 SH | 5,908,615 dollars | Higher by 105,994 Prior quarter: 314,548 | Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row |
| Point72 Asset Management, L.P. | 382,478 SH | 5,373,816 dollars | Higher by 215,274 Prior quarter: 167,204 | Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 381,317 SH | 5,357,505 dollars | Higher by 86,236 Prior quarter: 295,081 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 364,632 SH | 5,123,080 dollars | Higher by 59,765 Prior quarter: 304,867 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| Connor, Clark Lunn Investment Management Ltd. | 342,285 SH | 4,809,104 dollars | Higher by 125,128 Prior quarter: 217,157 | Open filing 0001596800-26-000018 Filed 2026-11-10 Dispute this row |
| Jump Financial, LLC Partly reported under another manager | 302,812 SH | 4,254,508 dollars | Higher by 130,065 Prior quarter: 172,747 | Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row |
| Cormorant Asset Management, LP Partly reported under another manager | 300,000 SH | 4,215,000 dollars | Not in the prior quarter’s filings read | Open filing 0001583977-26-000011 Filed 2026-11-16 Dispute this row |
| SCHRODER INVESTMENT MANAGEMENT GROUP Partly reported under another manager | 262,316 SH | 3,719,641 dollars | Higher by 121,430 Prior quarter: 140,886 | Open filing 0001140361-26-044129 Filed 2026-11-16 Dispute this row |
| UBS Group AG Partly reported under another manager | 221,367 SH | 3,110,206 dollars | Higher by 93,790 Prior quarter: 127,577 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| XTX Topco Ltd Partly reported under another manager | 218,952 SH | 3,076,276 dollars | Higher by 159,859 Prior quarter: 59,093 | Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row |
| Logos Global Management LP | 200,000 SH | 2,810,000 dollars | Lower by 925,000 Prior quarter: 1,125,000 | Open filing 0001172661-26-005128 Filed 2026-11-16 Dispute this row |
| BANK OF AMERICA CORP /DE/ Partly reported under another manager | 189,998 SH | 2,669,472 dollars | Lower by 296,957 Prior quarter: 486,955 | Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row |
| Walleye Capital LLC | 180,462 SH | 2,535,491 dollars | Lower by 184,810 Prior quarter: 365,272 | Open filing 0001758720-26-000007 Filed 2026-11-13 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- Jupiter Topco LLC 6,273,262 SH
- Balyasny Asset Management L.P. 878,726 SH
- Sixth Street Partners Management Company, L.P. 99,977 SH
- Atle Fund Management AB 88,556 SH
- Longaeva Partners L.P. 78,501 SH
- Corient Private Wealth LP 61,530 SH
- Maven Securities LTD 50,000 SH
- VOLORIDGE INVESTMENT MANAGEMENT, LLC 48,374 SH
- Voleon Capital Management LP 27,777 SH
- Engineers Gate Manager LP 22,619 SH
- Aquatic Capital Management LLC 22,431 SH
- Ghisallo Capital Management LLC 20,000 SH
- AQR CAPITAL MANAGEMENT LLC 13,311 SH
- NEW YORK STATE COMMON RETIREMENT FUND 11,522 SH
- Values First Advisors, Inc. 11,191 SH
- DELTEC ASSET MANAGEMENT LLC 9,436 SH
- MERCER GLOBAL ADVISORS INC /ADV 4,930 SH
- STRS OHIO 3,300 SH
- Pacer Advisors, Inc. 712 SH
- Optiver Holding B.V. 104 SH
- Integrated Wealth Concepts LLC 53 SH
- Quarry LP 39 SH
- NATIONAL BANK OF CANADA /FI/ 23 SH
- Ares Financial Consulting, LLC 20 SH
- Stone House Investment Management, LLC 8 SH
- Avion Wealth 7 SH
- Clearstead Advisors, LLC 3 SH
- Wealth Enhancement Trust Services, Inc. 1 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Paradigm BioCapital Advisors LP Common Stock, $0.0001 par value per share | 9.5 | 6,053,268.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-128317 Dispute this row |
| Paradigm BioCapital Advisors GP LLC Common Stock, $0.0001 par value per share | 9.5 | 6,053,268.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-128317 Dispute this row |
| Senai Asefaw, M.D. Common Stock, $0.0001 par value per share | 9.5 | 6,053,268.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-128317 Dispute this row |
| Paradigm BioCapital International Fund Ltd. Common Stock, $0.0001 par value per share | 8.4 | 5,335,522.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-128317 Dispute this row |
| RA Capital Management, L.P. Common Stock, $0.0001 par value per share | 2.9 | 1,835,542.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001346824-26-000283 Dispute this row |
| Peter Kolchinsky Common Stock, $0.0001 par value per share | 2.9 | 1,835,542.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001346824-26-000283 Dispute this row |
| Rajeev Shah Common Stock, $0.0001 par value per share | 2.9 | 1,835,542.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001346824-26-000283 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, $0.0001 par value per share | 2.9 | 1,835,542.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0001346824-26-000283 Dispute this row |
| Bellevue Group AG Common Stock | 6.8 | 4,293,937.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-26-128591 Dispute this row |
| Bellevue Asset Management AG Common Stock | 6.8 | 4,293,937.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-26-128591 Dispute this row |
| Venrock Healthcare Capital Partners III, L.P. Common Stock, $0.0001 par value per share | 5.9 | 3,858,984.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001738048-26-000094 Dispute this row |
| VHCP Co-Investment Holdings III, LLC Common Stock, $0.0001 par value per share | 5.9 | 3,858,984.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001738048-26-000094 Dispute this row |
| Venrock Healthcare Capital Partners EG, L.P. Common Stock, $0.0001 par value per share | 5.9 | 3,858,984.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001738048-26-000094 Dispute this row |
| VHCP Management III, LLC Common Stock, $0.0001 par value per share | 5.9 | 3,858,984.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001738048-26-000094 Dispute this row |
| VHCP Management EG, LLC Common Stock, $0.0001 par value per share | 5.9 | 3,858,984.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001738048-26-000094 Dispute this row |
| Nimish Shah Common Stock, $0.0001 par value per share | 5.9 | 3,858,984.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001738048-26-000094 Dispute this row |
| Bong Y. Koh Common Stock, $0.0001 par value per share | 5.9 | 3,858,984.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001738048-26-000094 Dispute this row |
| Franklin Templeton, Inc. Common Stock, par value $0.0001 per share | 6.0 | 3,807,236.00 | 09/30/2026 Filed 2026-10-28 | SCHEDULE 13G | Open filing 0000038777-26-000277 Dispute this row |
| Charles B. Johnson Common Stock, par value $0.0001 per share | 0 | 0.00 | 09/30/2026 Filed 2026-10-28 | SCHEDULE 13G | Open filing 0000038777-26-000277 Dispute this row |
| Rupert H. Johnson, Jr. Common Stock, par value $0.0001 per share | 0 | 0.00 | 09/30/2026 Filed 2026-10-28 | SCHEDULE 13G | Open filing 0000038777-26-000277 Dispute this row |
| BlackRock, Inc. Common Stock | 5.2 | 3,323,301 | 09/30/2026 Filed 2026-10-27 | SCHEDULE 13G | Open filing 0002012383-26-003871 Dispute this row |
| Paradigm BioCapital Advisors LP Common Stock, $0.0001 par value per share | 5.1 | 3,106,793.00 | 07/10/2026 Filed 2026-07-17 | SCHEDULE 13G | Open filing 0001104659-26-084623 Dispute this row |
| Paradigm BioCapital Advisors GP LLC Common Stock, $0.0001 par value per share | 5.1 | 3,106,793.00 | 07/10/2026 Filed 2026-07-17 | SCHEDULE 13G | Open filing 0001104659-26-084623 Dispute this row |
| Senai Asefaw, M.D. Common Stock, $0.0001 par value per share | 5.1 | 3,106,793.00 | 07/10/2026 Filed 2026-07-17 | SCHEDULE 13G | Open filing 0001104659-26-084623 Dispute this row |
| Paradigm BioCapital International Fund Ltd. Common Stock, $0.0001 par value per share | 4.5 | 2,738,259.00 | 07/10/2026 Filed 2026-07-17 | SCHEDULE 13G | Open filing 0001104659-26-084623 Dispute this row |
| Bellevue Group AG Common Stock | 5.0 | 3,057,996.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-096751 Dispute this row |
| Bellevue Asset Management AG Common Stock | 5.0 | 3,057,996.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-096751 Dispute this row |
| Venrock Healthcare Capital Partners III, L.P. Common Stock, $0.0001 par value | 8.3 | 5,145,330.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001231919-26-000932 Dispute this row |
| VHCP Co-Investment Holdings III, LLC Common Stock, $0.0001 par value | 8.3 | 5,145,330.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001231919-26-000932 Dispute this row |
| Venrock Healthcare Capital Partners EG, L.P. Common Stock, $0.0001 par value | 8.3 | 5,145,330.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001231919-26-000932 Dispute this row |
| VHCP Management III, LLC Common Stock, $0.0001 par value | 8.3 | 5,145,330.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001231919-26-000932 Dispute this row |
| VHCP Management EG, LLC Common Stock, $0.0001 par value | 8.3 | 5,145,330.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001231919-26-000932 Dispute this row |
| Nimish Shah Common Stock, $0.0001 par value | 8.3 | 5,145,330.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001231919-26-000932 Dispute this row |
| Bong Y. Koh Common Stock, $0.0001 par value | 8.3 | 5,145,330.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001231919-26-000932 Dispute this row |
| JANUS HENDERSON GROUP Ltd. Common Stock | 10.6 | 6,273,262 | 06/30/2026 Filed 2026-07-08 | SCHEDULE 13G/AAmendment 2 | Open filing 0001274173-26-000169 Dispute this row |
| Fairmount Funds Management LLC Common Stock, $0.0001 par value per share | 19.99 | 14,069,494.00 | 06/05/2026 Filed 2026-06-09 | SCHEDULE 13D/AAmendment 2 | Open filing 0001104659-26-071942 Dispute this row |
| Fairmount Healthcare Fund II L.P. Common Stock, $0.0001 par value per share | 16.22 | 11,413,677.00 | 06/05/2026 Filed 2026-06-09 | SCHEDULE 13D/AAmendment 2 | Open filing 0001104659-26-071942 Dispute this row |
| Fairmount Healthcare Co-Invest IV L.P. Common Stock, $0.0001 par value per share | 4.36 | 2,655,817.00 | 06/05/2026 Filed 2026-06-09 | SCHEDULE 13D/AAmendment 2 | Open filing 0001104659-26-071942 Dispute this row |
| Peter Evan Harwin Common Stock, $0.0001 par value per share | 19.99 | 14,069,494.00 | 06/05/2026 Filed 2026-06-09 | SCHEDULE 13D/AAmendment 2 | Open filing 0001104659-26-071942 Dispute this row |
| Tomas Kiselak Common Stock, $0.0001 par value per share | 19.99 | 14,063,511.00 | 06/05/2026 Filed 2026-06-09 | SCHEDULE 13D/AAmendment 2 | Open filing 0001104659-26-071942 Dispute this row |
| JANUS HENDERSON GROUP PLC Common Stock | 6.3 | 3,105,669 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001274173-26-000147 Dispute this row |
| BlackRock, Inc. Common Stock | 4.7 | 2,295,825 | 03/31/2026 Filed 2026-04-27 | SCHEDULE 13G/AAmendment 2 | Open filing 0002012383-26-001731 Dispute this row |
| Venrock Healthcare Capital Partners III, L.P. Common Stock, $0.0001 par value | 9.9 | 5,115,862.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000022 Dispute this row |
| VHCP Co-Investment Holdings III, LLC Common Stock, $0.0001 par value | 9.9 | 5,115,862.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000022 Dispute this row |
| Venrock Healthcare Capital Partners EG, L.P. Common Stock, $0.0001 par value | 9.9 | 5,115,862.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000022 Dispute this row |
| VHCP Management III, LLC Common Stock, $0.0001 par value | 9.9 | 5,115,862.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000022 Dispute this row |
| VHCP Management EG, LLC Common Stock, $0.0001 par value | 9.9 | 5,115,862.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000022 Dispute this row |
| Nimish Shah Common Stock, $0.0001 par value | 9.9 | 5,115,862.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000022 Dispute this row |
| Bong Y. Koh Common Stock, $0.0001 par value | 9.9 | 5,115,862.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 1 | Open filing 0001738048-26-000022 Dispute this row |
| JANUS HENDERSON GROUP PLC Common Stock | 6.2 | 3,063,457 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G | Open filing 0001274173-26-000080 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,256,735 filings read, dated 2004-06-14 to 2026-11-17: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 1 |
| 2016 | 204,322 |
| 2017 | 202,494 |
| 2018 | 202,048 |
| 2019 | 193,638 |
| 2020 | 144,184 |
| 2021 | 224,474 |
| 2022 | 158,941 |
| 2023 | 199,811 |
| 2024 | 209,823 |
| 2025 | 235,520 |
| 2026 | 260,174 |
Filings made before the SEC required XML are listed, not extracted.